UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052576
Receipt number R000059998
Scientific Title Effect of Powdered Morus australis Leaves on Arterial Stiffness after Sucrose Ingestion
Date of disclosure of the study information 2023/10/23
Last modified on 2024/10/23 09:37:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Powdered Morus australis Leaves on Arterial Stiffness after Sucrose Ingestion

Acronym

Effect of Powdered Morus australis Leaves on Arterial Stiffness after Sucrose Ingestion

Scientific Title

Effect of Powdered Morus australis Leaves on Arterial Stiffness after Sucrose Ingestion

Scientific Title:Acronym

Effect of Powdered Morus australis Leaves on Arterial Stiffness after Sucrose Ingestion

Region

Japan


Condition

Condition

Arterial stiffening associated with Postprandial Hyperglycemia

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effect of powdered Morus australis on arterial stiffness after sucrose ingestion.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Arterial stiffness

Key secondary outcomes

Blood glucose level


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of powdered Morus australis

Interventions/Control_2

Sucrose ingestion

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

40 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy young individuals

Key exclusion criteria

Smoking
Obesity
Hypertension

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Kume

Organization

Osaka Institute of Technology

Division name

Faculty of Information Science and Technology

Zip code

573-0196

Address

1-79-1, Kitayama, Hirakata-City, Osaka

TEL

0728665368

Email

kumedai128@gmail.com


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Kume

Organization

Osaka Institute of Technology

Division name

Faculty of Information Science and Technology

Zip code

573-0196

Address

1-79-1, Kitayama, Hirakata-City, Osaka

TEL

0728665368

Homepage URL


Email

kumedai128@gmail.com


Sponsor or person

Institute

Osaka Institute of Technology

Institute

Department

Personal name

Daisuke Kume


Funding Source

Organization

Urasoe-City

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Institute of Technology

Address

1-79-1, Kitayama, Hirakata-City, Osaka

Tel

0728665368

Email

kumedai128@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 23 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

12

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 10 Month 23 Day

Date of IRB

2023 Year 10 Month 17 Day

Anticipated trial start date

2023 Year 10 Month 23 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 10 Month 23 Day

Last modified on

2024 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059998